Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
Sifat Sharmin(The Royal Melbourne Hospital), Éric Berger, Gilles Defer(Centre Hospitalier Universitaire de Caen Normandie), Murat Terzi(Ondokuz Mayıs University), de Sèze(Université de Strasbourg), Franco Granella(University of Parma), Jeannette Lechner‐Scott(John Hunter Hospital), María Trojano(University of Bari Aldo Moro), Davide Maimone(Ospedale Garibaldi), Katherine Buzzard(The Royal Melbourne Hospital), Dana Horáková(Charles University), Bassem Yamout(American University of Beirut Medical Center), Alessandra Lugaresi(Istituto delle Scienze Neurologiche di Bologna), Élisabeth Maillart(Sorbonne Université), Aurélie Ruet(Université de Bordeaux), Johanna Balslev Andersen(University of Copenhagen), Marco Onofrj(University of Chieti-Pescara), Anneke van der Walt(The Alfred Hospital), Romain Casey(Université Claude Bernard Lyon 1), Julie Prévost(Cegep de Saint Jerome), Raed Alroughani(Amiri Hospital), Cavit Boz(Farabi Hastanesi), Pierre Duquette(Centre Hospitalier de l’Université de Montréal), Pamela McCombe(The University of Queensland), François Grand’Maison, Mark Slee(Flinders University), Hélène Zéphir(Université de Lille), Pierre Grammond(Centre intégré de santé et de services sociaux de Chaudière-Appalaches), Recai Türkoğlu(Haydarpaşa Numune Eğitim ve Araştırma Hastanesi), Daniele Spitaleri(Azienda Ospedaliera S.Giuseppe Moscati), Francesco Patti(University of Catania), Alexandre Prat(Université de Montréal), Eva Havrdová(Charles University), Christine Lebrun‐Frénay(Université Côte d'Azur), Patrizia Sola(Azienda Ospedaliero-Universitaria di Modena), Tünde Csépány(University of Debrecen), Mathilde Lefort(Inserm), Emmanuelle Leray(Inserm), Gilles Edan(Centre National de la Recherche Scientifique), Serkan Özakbaş(İzmir University of Economics), Steve Vucic(Westmead Hospital), Bart Van Wijmeersch(Hasselt University), Marc Girard(Université de Montréal), Marc Debouverie(Centre Hospitalier Régional et Universitaire de Nancy), Pierre Labauge, Olga Skibina(Box Hill Hospital), Thibault Moreau(CHU Dijon Bourgogne), Jonathan Ciron(Université de Poitiers), Guillermo Izquierdo(Hospital Universitario Virgen Macarena), Diana Ferraro(Azienda Ospedaliero-Universitaria di Modena)
Cited by 12
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k